Article
The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.
Epidemiology (Cambridge, Mass.) - 1 Nov 2003
Rutter Joni L, Chatterjee Nilanjan, Wacholder Sholom, Struewing Jeffrey
Abstract excerpt
SUMMARY: BACKGROUND Over-expression of the human epidermal growth factor receptor 2 (Her2) protooncogene is associated with poor prognosis among female patients with breast cancer. A polymorphism in the HER2 gene (I655V) has been associated with an elevated risk of breast cancer in some ethnic gr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
